Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis

BACKGROUND: Treatment of latent tuberculosis infection (LTBI) in high-risk groups is an effective strategy for TB control and elimination in low incidence settings. A nine-month course of daily isoniazid (INH) has been the longest prescribed therapy; however, completion rates are suboptimal. We need...

Descripción completa

Detalles Bibliográficos
Autores principales: Séraphin, Marie Nancy, Hsu, HsiaoChu, Chapman, Helena J., de Andrade Bezerra, Joanne L., Johnston, Lori, Yang, Yang, Lauzardo, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724263/
https://www.ncbi.nlm.nih.gov/pubmed/31481046
http://dx.doi.org/10.1186/s12889-019-7524-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724263/
https://www.ncbi.nlm.nih.gov/pubmed/31481046
http://dx.doi.org/10.1186/s12889-019-7524-4

Ejemplares similares